Zbtb7b defines a compensatory mechanism in MASLD‐related HCC progression by suppressing H19‐mediated hepatic lipid deposition
Abstract Hepatocellular carcinoma (HCC) is a widely prevalent type of primary liver cancer. However, strategies for pretumor intervention are still limited. In this study, a liver‐specific Zbtb7b knockout mouse model was used to evaluate the role of Zbtb7b in metabolic dysfunction‐associated steatot...
Saved in:
| Main Authors: | Yinglin Han, Kaimin Wu, Xin Peng, Yinkun Fu, Wenyan Li, Jing Ma, He Jiang, Xu‐Yun Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Physiological Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.14814/phy2.70160 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipid metabolism in MASLD and MASH: From mechanism to the clinicKeypoints
by: Fabrizia Carli, et al.
Published: (2024-12-01) -
Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types
by: Peiyi Xu, et al.
Published: (2024-12-01) -
Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts through regulation of the HOXA6/ZBTB12 axis
by: Liu Haibo, et al.
Published: (2023-09-01) -
Essential roles of B cell subsets in the progression of MASLD and HCC
by: Nataliia Petriv, et al.
Published: (2024-12-01) -
Case report: Novel multi-exon homozygous deletion of ZBTB24 causes immunodeficiency, centromeric instability, and facial anomalies syndrome 2
by: Yan Long, et al.
Published: (2025-01-01)